Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Clinical trial NCT05407987 · RECRUITING

Trial details

NCT number: NCT05407987
Sponsor: AHS Cancer Control Alberta
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gynecologic Cancer Anemia Iron-deficiency

Start date: 2025-04-08
Primary completion: 2026-12-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.